Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission.

Pregnant HIV-infected women were screened for the development of HIV-1 drug resistance after implementation of a triple-antiretroviral transmission prophylaxis as recommended by the WHO in 2006. The study offered the opportunity to compare amplicon-based 454 ultra-deep sequencing (UDS) and allele-sp...

Full description

Bibliographic Details
Main Authors: Andrea Hauser, Claudia Kuecherer, Andrea Kunz, Piotr Wojtek Dabrowski, Aleksandar Radonić, Andreas Nitsche, Stefanie Theuring, Norbert Bannert, Julius Sewangi, Paulina Mbezi, Festo Dugange, Gundel Harms, Karolin Meixenberger
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4607442?pdf=render
_version_ 1818953102905049088
author Andrea Hauser
Claudia Kuecherer
Andrea Kunz
Piotr Wojtek Dabrowski
Aleksandar Radonić
Andreas Nitsche
Stefanie Theuring
Norbert Bannert
Julius Sewangi
Paulina Mbezi
Festo Dugange
Gundel Harms
Karolin Meixenberger
author_facet Andrea Hauser
Claudia Kuecherer
Andrea Kunz
Piotr Wojtek Dabrowski
Aleksandar Radonić
Andreas Nitsche
Stefanie Theuring
Norbert Bannert
Julius Sewangi
Paulina Mbezi
Festo Dugange
Gundel Harms
Karolin Meixenberger
author_sort Andrea Hauser
collection DOAJ
description Pregnant HIV-infected women were screened for the development of HIV-1 drug resistance after implementation of a triple-antiretroviral transmission prophylaxis as recommended by the WHO in 2006. The study offered the opportunity to compare amplicon-based 454 ultra-deep sequencing (UDS) and allele-specific real-time PCR (ASPCR) for the detection of drug-resistant minor variants in the HIV-1 reverse transcriptase (RT).Plasma samples from 34 Tanzanian women were previously analysed by ASPCR for key resistance mutations in the viral RT selected by AZT, 3TC, and NVP (K70R, K103N, Y181C, M184V, T215Y/F). In this study, the RT region of the same samples was investigated by amplicon-based UDS for resistance mutations using the 454 GS FLX System.Drug-resistant HIV-variants were identified in 69% (20/29) of women by UDS and in 45% (13/29) by ASPCR. The absolute number of resistance mutations identified by UDS was twice that identified by ASPCR (45 vs 24). By UDS 14 of 24 ASPCR-detected resistance mutations were identified at the same position. The overall concordance between UDS and ASPCR was 61.0% (25/41). The proportions of variants quantified by UDS were approximately 2-3 times lower than by ASPCR. Amplicon generation from samples with viral loads below 20,000 copies/ml failed more frequently by UDS compared to ASPCR (limit of detection = 650 copies/ml), resulting in missing or insufficient sequence coverage.Both methods can provide useful information about drug-resistant minor HIV-1 variants. ASPCR has a higher sensitivity than UDS, but is restricted to single resistance mutations. In contrast, UDS is limited by its requirement for high viral loads to achieve sufficient sequence coverage, but the sequence information reveals the complete resistance patterns within the genomic region analysed. Improvements to the UDS limit of detection are in progress, and UDS could then facilitate monitoring of drug-resistant minor variants in the HIV-1 quasispecies.
first_indexed 2024-12-20T10:00:56Z
format Article
id doaj.art-09a6524b36564a0e8ae7dd8b65d120f6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T10:00:56Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-09a6524b36564a0e8ae7dd8b65d120f62022-12-21T19:44:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e014080910.1371/journal.pone.0140809Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission.Andrea HauserClaudia KuechererAndrea KunzPiotr Wojtek DabrowskiAleksandar RadonićAndreas NitscheStefanie TheuringNorbert BannertJulius SewangiPaulina MbeziFesto DugangeGundel HarmsKarolin MeixenbergerPregnant HIV-infected women were screened for the development of HIV-1 drug resistance after implementation of a triple-antiretroviral transmission prophylaxis as recommended by the WHO in 2006. The study offered the opportunity to compare amplicon-based 454 ultra-deep sequencing (UDS) and allele-specific real-time PCR (ASPCR) for the detection of drug-resistant minor variants in the HIV-1 reverse transcriptase (RT).Plasma samples from 34 Tanzanian women were previously analysed by ASPCR for key resistance mutations in the viral RT selected by AZT, 3TC, and NVP (K70R, K103N, Y181C, M184V, T215Y/F). In this study, the RT region of the same samples was investigated by amplicon-based UDS for resistance mutations using the 454 GS FLX System.Drug-resistant HIV-variants were identified in 69% (20/29) of women by UDS and in 45% (13/29) by ASPCR. The absolute number of resistance mutations identified by UDS was twice that identified by ASPCR (45 vs 24). By UDS 14 of 24 ASPCR-detected resistance mutations were identified at the same position. The overall concordance between UDS and ASPCR was 61.0% (25/41). The proportions of variants quantified by UDS were approximately 2-3 times lower than by ASPCR. Amplicon generation from samples with viral loads below 20,000 copies/ml failed more frequently by UDS compared to ASPCR (limit of detection = 650 copies/ml), resulting in missing or insufficient sequence coverage.Both methods can provide useful information about drug-resistant minor HIV-1 variants. ASPCR has a higher sensitivity than UDS, but is restricted to single resistance mutations. In contrast, UDS is limited by its requirement for high viral loads to achieve sufficient sequence coverage, but the sequence information reveals the complete resistance patterns within the genomic region analysed. Improvements to the UDS limit of detection are in progress, and UDS could then facilitate monitoring of drug-resistant minor variants in the HIV-1 quasispecies.http://europepmc.org/articles/PMC4607442?pdf=render
spellingShingle Andrea Hauser
Claudia Kuecherer
Andrea Kunz
Piotr Wojtek Dabrowski
Aleksandar Radonić
Andreas Nitsche
Stefanie Theuring
Norbert Bannert
Julius Sewangi
Paulina Mbezi
Festo Dugange
Gundel Harms
Karolin Meixenberger
Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission.
PLoS ONE
title Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission.
title_full Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission.
title_fullStr Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission.
title_full_unstemmed Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission.
title_short Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission.
title_sort comparison of 454 ultra deep sequencing and allele specific real time pcr with regard to the detection of emerging drug resistant minor hiv 1 variants after antiretroviral prophylaxis for vertical transmission
url http://europepmc.org/articles/PMC4607442?pdf=render
work_keys_str_mv AT andreahauser comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT claudiakuecherer comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT andreakunz comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT piotrwojtekdabrowski comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT aleksandarradonic comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT andreasnitsche comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT stefanietheuring comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT norbertbannert comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT juliussewangi comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT paulinambezi comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT festodugange comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT gundelharms comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission
AT karolinmeixenberger comparisonof454ultradeepsequencingandallelespecificrealtimepcrwithregardtothedetectionofemergingdrugresistantminorhiv1variantsafterantiretroviralprophylaxisforverticaltransmission